- Home
- NARI vs AB Comparison
NARI vs AB Comparison
Compare NARI & AB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NARI
- AB
- Stock Information
- Founded
- NARI 2011
- AB 1987
- Country
- NARI United States
- AB United States
- Employees
- NARI N/A
- AB N/A
- Industry
- NARI Medical/Dental Instruments
- AB Investment Managers
- Sector
- NARI Health Care
- AB Finance
- Exchange
- NARI Nasdaq
- AB Nasdaq
- Market Cap
- NARI 4.7B
- AB 4.3B
- IPO Year
- NARI 2020
- AB 1988
- Fundamental
- Price
- NARI $79.87
- AB $39.42
- Analyst Decision
- NARI Hold
- AB Strong Buy
- Analyst Count
- NARI 12
- AB 5
- Target Price
- NARI $69.22
- AB $43.00
- AVG Volume (30 Days)
- NARI 4.8M
- AB 465.5K
- Earning Date
- NARI 02-26-2025
- AB 02-06-2025
- Dividend Yield
- NARI N/A
- AB 7.61%
- EPS Growth
- NARI N/A
- AB 57.32
- EPS
- NARI N/A
- AB 3.49
- Revenue
- NARI $574,498,000.00
- AB $134,096,000.00
- Revenue This Year
- NARI $24.62
- AB N/A
- Revenue Next Year
- NARI $18.00
- AB $6.36
- P/E Ratio
- NARI N/A
- AB $11.23
- Revenue Growth
- NARI 22.41
- AB N/A
- 52 Week Low
- NARI $36.73
- AB $30.57
- 52 Week High
- NARI $79.89
- AB $40.86
- Technical
- Relative Strength Index (RSI)
- NARI 80.06
- AB 55.16
- Support Level
- NARI $79.60
- AB $39.25
- Resistance Level
- NARI $79.76
- AB $40.86
- Average True Range (ATR)
- NARI 0.18
- AB 1.07
- MACD
- NARI -0.79
- AB -0.01
- Stochastic Oscillator
- NARI 93.33
- AB 68.74
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (42% of assets under management), retail (41%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of October 2024, AB had $793 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (42%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.